Truist analyst David MacDonald raised the firm’s price target on Tenet Healthcare to $60 from $55 and keeps a Buy rating on the shares as part of a broader research note on Hospitals. The analyst notes that his Q4 hospital survey suggests "decent utilization" with sequential improvement across care settings and a labor environment that is showing signs of improvement despite the "difficult backdrop".
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on THC: